Have a personal or library account? Click to login
Iron Citrate (Synthesit) Supplementation During Pancreas Cancer Showed Surprising Results – Case Study Cover

Iron Citrate (Synthesit) Supplementation During Pancreas Cancer Showed Surprising Results – Case Study

By: Patrik Kusnir  
Open Access
|Dec 2023

Figures & Tables

Fig. 1

Comparison of various haematological parameters

Analyses of blood plasma proteins done in December 2019 and March 2023_ Parameters that were out of the reference range are highlighted_ Values marked as dash mean no data available_

December 2019March 2023
Fraction%Reference range %g/lg/lReference range
Albumin62.960.3 – 72.844.041.437.5 – 50.1
Alpha1-globulins2.21.0 – 2.61.53.01.9 – 4.6
Alpha2-globulins8.67.2 – 11.86.06.14.8 – 10.5
Beta1-globulins6.05.6 – 9.14.2--
Beta2-globulins3.32.2 – 5.72.3--
Beta-globulins---6.84.8 – 11.0
Gamma-globulins17.0>6.2 – 15.411.911.76.2 – 15.1
Albumin/Globulin ratio1.701.2 – 2.0-1.51.2 – 2.0
Monoclonal IgG kappa0.9-0.6--
Total protein69.962 – 81-6762 – 81

Blood analyses before taking Synthesit in February 2020, during taking in July 2021, and after taking it in March 2023_ Parameters that were out of the reference range are highlighted_ Values marked as dash mean no data available_

ParameterBefore taking Synthesit 02/2020During taking Synthesit 7/2021After taking Synthesit 03/2023Reference rangeUnit of measurement
Haematocrit40.9-42.735.0 – 47.0%
Haemoglobin14.014.814.511.7 – 16.0g/dl
Erythrocytes4.584.904.723.80 – 5.30*106/μl
Thrombocytes116260123150 – 400*103/μl
Leukocytes7.074.206.804.50 – 11*103/μl
Neutrophils (total), %40.306648.4048.0 – 78.0%
Lymphocytes, %50.5-44.119.0 – 37.0%
Monocytes, %7.5-5.63.0 – 11.0%
Eosinophils, %1.431.61.0 – 5.0%
Basophils, %0.3-0.3<1.0%
Neutrophils abs.2.85-3.291.56 – 6.13*103/μl
Lymphocytes abs.3.57-3.001.18 – 3.74*103/μl
Monocytes abs.0.5310.380.20 – 0.95*103/μl
Eosinophils abs.0.10-0.110.00 – 0.70*103/μl
Basophils abs.0.02-0.020.00 – 0.20*103/μl
Erythrocyte Sedimentation Rate (ESR)1247<30mm/h
DOI: https://doi.org/10.2478/acm-2023-0014 | Journal eISSN: 1338-4139 | Journal ISSN: 1335-8421
Language: English
Page range: 107 - 116
Submitted on: Aug 9, 2023
|
Accepted on: Nov 11, 2023
|
Published on: Dec 31, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year

© 2023 Patrik Kusnir, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.